These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children. Tumgor G, Arikan C, Kilic M, Aydogdu S. Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488 [Abstract] [Full Text] [Related]
23. [Clinical study of pulmonary infection in kidney transplantation recipients taking new immunosuppressant]. Zhang YX, Yu LX, Fu SJ, Ye JS, Liu XY. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1037-40. PubMed ID: 18583258 [Abstract] [Full Text] [Related]
27. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Vivarelli M, Cucchetti A, La Barba G, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD. Ann Surg; 2008 Nov 28; 248(5):857-62. PubMed ID: 18948815 [Abstract] [Full Text] [Related]
29. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy. Sato K, Iwane T, Sekiguchi S, Nakamura A, Akamatsu Y, Kawagishi N, Miyagi S, Takeda I, Sato A, Fujimori K, Satomi S. Transplant Proc; 2009 Nov 28; 41(1):229-32. PubMed ID: 19249521 [Abstract] [Full Text] [Related]
30. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation. Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M. Transplant Proc; 2008 Dec 28; 40(10):3455-9. PubMed ID: 19100412 [Abstract] [Full Text] [Related]
31. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G. Liver Transpl; 2008 May 28; 14(5):651-9. PubMed ID: 18433069 [Abstract] [Full Text] [Related]
32. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Misawa A, Takeuchi Y, Hibi S, Todo S, Imashuku S, Sawada T. Bone Marrow Transplant; 2000 Feb 28; 25(3):331-4. PubMed ID: 10673708 [Abstract] [Full Text] [Related]
33. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient. Ko WJ, Lin FL, Wang SS, Chu SH. J Heart Lung Transplant; 1997 Sep 28; 16(9):980-2. PubMed ID: 9322151 [No Abstract] [Full Text] [Related]
35. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft]. Shi WY, Liu T, Xie LX, Wang SG. Zhonghua Yan Ke Za Zhi; 2006 Apr 28; 42(4):299-304. PubMed ID: 16762204 [Abstract] [Full Text] [Related]
36. Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study. Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, Sugawara S. J Rheumatol; 2004 Feb 28; 31(2):243-51. PubMed ID: 14760792 [Abstract] [Full Text] [Related]
37. [Dental and oral aspects in pediatric liver transplant patients. A comparison between the effects of cyclosporine A and FK 506]. Savoldi E, Rolfi A, Majorana A, Alberti D. Minerva Stomatol; 1997 Mar 28; 46(3):73-7. PubMed ID: 9173223 [Abstract] [Full Text] [Related]